Orthofix (OFIX) Q4 Earnings Lag Estimates

Company Performance - Orthofix reported quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.06 per share, compared to a loss of $0.10 per share a year ago, representing an earnings surprise of -66.67% [1] - The company posted revenues of $215.66 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.53%, and showing an increase from year-ago revenues of $200.42 million [2] - Over the last four quarters, Orthofix has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Outlook - The immediate price movement of Orthofix's stock will depend on management's commentary during the earnings call and the sustainability of earnings expectations [3][4] - Orthofix shares have increased about 4% since the beginning of the year, outperforming the S&P 500's gain of 1.7% [3] Earnings Estimates - The current consensus EPS estimate for the coming quarter is -$0.21 on revenues of $200.2 million, and -$0.23 on revenues of $848 million for the current fiscal year [7] - The estimate revisions trend for Orthofix is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Industry Context - The Medical - Instruments industry, to which Orthofix belongs, is currently in the top 32% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8]